Las Vegas Sands Chairman and CEO Sheldon Adelson was back on deck for the company’s 3Q19 earnings call on Wednesday, almost eight months after it was first revealed he was undergoing treatment for non-Hodgkin’s lymphoma.
The 86-year-old had missed the previous three earnings calls, dating back to January of this year, but seemed in good spirits as he spoke with investors about his firm’s results, which saw a 3.5% decline in revenue compared with the same period last year.
“Let me begin by saying I feel good, I’m very happy to be here with Rob [Goldstein], Patrick [Dumont] and the team and I look forward to our discussion today,” Adelson said.
“Let me also say that I am extremely touched by all the calls and emails I’ve received over the past several months. It has been remarkable to hear from so many people, including many of you joining us today.
“I deeply appreciate the well-wishes and everyone who took the time to reach out to me. It certainly means a lot.”
LVS revealed in March that Adelson was on restricted duty, with a spokesman stating at the time, “Mr Adelson is still dealing with certain side effects from the medication he is taking for the treatment of non-Hodgkin’s lymphoma.
“These side effects have restricted his availability to travel or keep regular office hours.”
However, it added, “the company anticipates that Mr Adelson will return to his regular schedule at the completion of his treatment.”
The Inside Asian Gaming team is delighted to see Sheldon Adelson back on deck. Mr Adelson has ranked number one in the Asian Gaming Power 50 for the past six years running and without any shadow of a doubt has been a transformative figure in the global integrated resort industry, particularly in Macau. It is great to see him back at work.
